AGAINST BREAST CANCER LIMITED
Registered charity 1121258 · accounts filings on the Charity Commission register
Against Breast Cancer funds a research programme into the treatment and prevention of breast cancer, focusing particularly on secondary spread and survival after diagnosis.We are leading the worlds largest study into the diet and lifestyle of breast cancer patients.Our Research Teams quest to produce a breast cancer vaccine and ultimately a cure for breast cancer.
Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts
Financial health, per its FY2024 accounts
The accounts state that the charity achieved a net income of £104,179 for the year ended 31 December 2024, a significant improvement from the previous year's loss. The trustees report that the charity remains committed to financial growth and stability, with total reserves increasing to £458,168. The auditor confirmed that the financial statements are prepared on a going concern basis with no material uncertainties identified.
Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.
What the accounts disclose
Reserves policy: three to six months operating costs (held: £448k)
“Against Breast Cancer decided on a policy of holding 3 to 6 months operating costs. A figure of £150,000 was considered to be a reasonable level of reserves to be held that would enable the charity to meet all of its liabilities should operations have to cease at some point in the future.” — page 13
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Trade balance owed by subsidiary
“At 31st December 2024 the Charity was owed £62,107 (2023: £64,599) by its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
“At 31st December 2024 the Charity owed £1 (2023: £nil) to its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Trade balance owed to subsidiary
“At 31st December 2024 the Charity was owed £62,107 (2023: £64,599) by its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
“At 31st December 2024 the Charity owed £1 (2023: £nil) to its 100% owned subsidiary, Against Breast Cancer Trading Limited as a result of trade charges, and charity income received by the subsidiary less expenditure incurred on the subsidiary's behalf.” — page 34
Per its FY2024 accounts as filed with the Charity Commission.
Accounts audited by Xeinadin Audit Limited. Discloses 5 of 6 completeness components.
Public fundraising profile: JustGiving — Against Breast Cancer (matched by registered charity number).
Leadership, per the charity’s website
- Dr Anthony Leathem — Founder (source)
Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.
Property (HM Land Registry)
1 registered titlein England and Wales held by the charity’s company or corporate body (1 freehold); recorded price paid £275k. All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.
Public profiles (found on the charity’s own website): facebook · instagram
Structured financials (annual return, FY ending 31/12/2024)
Cost of raising funds
£662k
Reported reserves equal ~4.2 months of spending — below the median for charities its size (median 4.8 months; benchmarks).
Trustee list from the Charity Commission register (current, not historical).
Operates in: Throughout England And Wales
Income and spending
Common questions
Is AGAINST BREAST CANCER LIMITED financially healthy?
Per its FY2024 accounts: The accounts state that the charity achieved a net income of £104,179 for the year ended 31 December 2024, a significant improvement from the previous year's loss. The trustees report that the charity remains committed to financial growth and stability, with total reserves increasing to £458,168. The auditor confirmed that the financial statements are prepared on a going concern basis with no material uncertainties identified. Its FY2024 accounts were audited by Xeinadin Audit Limited.
Government & lottery funding
Grants to this charity published as open data by government and lottery funders (360Giving).
Funders of similar charities
Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.
Charities like this
Semantically similar by activities and financial character, from our analysed corpus. Compare with Prevent Breast Cancer.
Side by side with its peers
Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.